Axa S.A. Harvard Bioscience Inc Transaction History

Axa S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$1.93 - $4.59 $26,381 - $62,740	-13,669 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$3.03 - $5.0 $41,417 - $68,345	13,669 New	13,669 $43,000
Q2 2018 Aug 13, 2018	SELL	$4.2 - $5.95 $412,230 - $583,992	-98,150 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$3.3 - $5.15 $228,855 - $357,152	-69,350 Reduced 41.4%	98,150 $491,000
Q4 2017 Feb 13, 2018	BUY	$3.08 - $3.8 $73,920 - $91,200	24,000 Added 16.72%	167,500 $553,000
Q3 2017 Nov 13, 2017	BUY	$2.7 - $3.75 $387,450 - $538,125	143,500	143,500 $538,000

103

32M

1.2K

1.2K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $99.9M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.